Browsing by Author Chen, ST

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 5 of 5
TitleAuthor(s)Issue Date
 
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
Journal:Breast Cancer Research and Treatment
Dai, MSFeng, YHChen, SWMasuda, NYau, TChen, STLu, YSYap, YSAng, PCSChu, SCKwong, ALee, KSOw, SKim, SBLin, JChung, HCNgan, RKok, VCRau, KMSangai, TNg, TYTseng, LMBryce, RBebchuk, JChen, MCHou, MF
2021
 
CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza virus pathogenicity in vivo
Journal:Journal of Virology
Teng, OChen, STHsu, TLSia, SFCole, SLDoak, SAHsu, TYZheng, JTTu, WBruzzone, RPeiris, JSMHsieh, SALYen, H
2017
 
Genome-Wide 3′-UTR Single Nucleotide Polymorphism Association Study Identifies Significant Prostate Cancer Risk-Associated Functional Loci at 8p21.2 in Chinese Population
Journal:Advanced Science Open Access
Zhang, NHuang, DJiang, GLChen, STRuan, XHChen, HTHunag, JYLiu, ATsu, HLJNa, R
2022
 
Genome‐Wide 3′‐UTR Single Nucleotide Polymorphism Association Study Identifies Significant Prostate Cancer Risk‐Associated Functional Loci at 8p21.2 in Chinese Population
Journal:Advanced Science
Zhang, NHuang, DJiang, GJChen, STRuan, XHChen, HTHunag, JYLiu, AZhag, WHLin, XLWu, YSZhang, QLi, JTsu, HLJWei, GHNa, R
2022
 
Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinoma
Journal:Heliyon
Chen, STGuo, TJZhang, ECWang, TJiang, GLWu, YSWang, XNa, RZhang, N
2022
Showing results 1 to 5 of 5